| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy
|
Kossai, M.
|
|
2015
|
89 |
3 |
p. 306-310
5 p.
|
artikel
|
| 2 |
Carboplatin plus pemetrexed offers superior cost-effectiveness compared to pemetrexed in patients with advanced non-small cell lung cancer and performance status 2
|
Schluckebier, Luciene
|
|
2015
|
89 |
3 |
p. 274-279
6 p.
|
artikel
|
| 3 |
Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer
|
Liu, Dongyang
|
|
2015
|
89 |
3 |
p. 262-267
6 p.
|
artikel
|
| 4 |
Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients
|
Shan, Ling
|
|
2015
|
89 |
3 |
p. 337-342
6 p.
|
artikel
|
| 5 |
Contents
|
|
|
2015
|
89 |
3 |
p. v-vi
nvt p.
|
artikel
|
| 6 |
Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S.
|
Kumar, Gayathri
|
|
2015
|
89 |
3 |
p. 294-300
7 p.
|
artikel
|
| 7 |
Cytotoxic chemotherapy may overcome the development of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) therapy
|
Kanda, Shintaro
|
|
2015
|
89 |
3 |
p. 287-293
7 p.
|
artikel
|
| 8 |
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug–drug interaction
|
Das, Millie
|
|
2015
|
89 |
3 |
p. 280-286
7 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2015
|
89 |
3 |
p. iii-
1 p.
|
artikel
|
| 10 |
Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI
|
Klempner, Samuel J.
|
|
2015
|
89 |
3 |
p. 357-359
3 p.
|
artikel
|
| 11 |
Frequent aerogenous spread with decreased E-cadherin expression of ROS1-rearranged lung cancer predicts poor disease-free survival
|
Jin, Yan
|
|
2015
|
89 |
3 |
p. 343-349
7 p.
|
artikel
|
| 12 |
Icotinib might be effective for the treatment of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive EGFR mutations
|
Gong, Lei
|
|
2015
|
89 |
3 |
p. 268-273
6 p.
|
artikel
|
| 13 |
IL1B gene polymorphisms, age and the risk of non-small cell lung cancer in a Chinese population
|
Li, Yanan
|
|
2015
|
89 |
3 |
p. 232-237
6 p.
|
artikel
|
| 14 |
Induction chemotherapy with cetuximab, vinorelbine–cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine–cisplatin in patients with unresectable stage III non-small cell lung cancer
|
Liu, Di
|
|
2015
|
89 |
3 |
p. 249-254
6 p.
|
artikel
|
| 15 |
Polymorphisms in alternative splicing associated genes are associated with lung cancer risk in a Chinese population
|
Shen, Wei
|
|
2015
|
89 |
3 |
p. 238-242
5 p.
|
artikel
|
| 16 |
Predictors of lung cancer among former asbestos-exposed workers
|
Świątkowska, Beata
|
|
2015
|
89 |
3 |
p. 243-248
6 p.
|
artikel
|
| 17 |
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study
|
Ferrero, Cinzia
|
|
2015
|
89 |
3 |
p. 350-356
7 p.
|
artikel
|
| 18 |
Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer
|
Nishiyama, Akihiro
|
|
2015
|
89 |
3 |
p. 301-305
5 p.
|
artikel
|
| 19 |
Second line therapy in malignant pleural mesothelioma: A systematic review
|
Buikhuisen, Wieneke A.
|
|
2015
|
89 |
3 |
p. 223-231
9 p.
|
artikel
|
| 20 |
Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype
|
Zhang, Liyi
|
|
2015
|
89 |
3 |
p. 320-328
9 p.
|
artikel
|
| 21 |
Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis
|
Kuiper, Justine L.
|
|
2015
|
89 |
3 |
p. 255-261
7 p.
|
artikel
|
| 22 |
Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma
|
Kadota, Kyuichi
|
|
2015
|
89 |
3 |
p. 329-336
8 p.
|
artikel
|
| 23 |
Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients
|
Dimitrakopoulos, Foteinos-Ioannis D.
|
|
2015
|
89 |
3 |
p. 311-319
9 p.
|
artikel
|
Tijdschrift beschrijving